Race for a coronavirus vaccine: thanks in part to institutional support, CanSino biologics, Moderna therapeutics, and other developers are exploring diverse …
D Ricks - Genetic Engineering & Biotechnology News, 2020 - liebertpub.com
Vaccine developers are fast-tracking new constructs of various kinds—traditional vaccines,
RNA vaccines, DNA vaccines, and others—in hopes of catching up with COVID-19, the …
RNA vaccines, DNA vaccines, and others—in hopes of catching up with COVID-19, the …
[HTML][HTML] Whither COVID-19 vaccines?
L DeFrancesco - Nature biotechnology, 2020 - nature.com
Whither COVID-19 vaccines? | Nature Biotechnology Skip to main content Thank you for
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the …
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the …
COVID-19: top 60 drug treatments in development: the biopharma industry is ramping up the development of dozens of potential drug therapies and clinical testing in …
A Philippidis - Genetic Engineering & Biotechnology News, 2020 - liebertpub.com
Alex Philippidis n March 16 at the Kaiser Permanente Washington Health Research Institute
in Seattle, doctors injected 43-year-old Jennifer Haller with the first experimental vaccine …
in Seattle, doctors injected 43-year-old Jennifer Haller with the first experimental vaccine …
[HTML][HTML] Are genetic vaccines the right weapon against COVID-19?
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
Coronavirus disease (COVID-19), emerged in China in December 2019. Investigators have …
Coronavirus disease (COVID-19), emerged in China in December 2019. Investigators have …
[HTML][HTML] Current updates on COVID-19 vaccines and therapeutics: as of June 2022
W Lee, SJ Kim - Biotechnology and Bioprocess Engineering, 2022 - Springer
Since COVID-19, caused by SARS-CoV-2 infection, has become a global issue, many
vaccines and therapeutic candidates have been developed or are being developed against …
vaccines and therapeutic candidates have been developed or are being developed against …
[HTML][HTML] Coronavirus variants—will new mRNA vaccines meet the challenge?
J Welsh - Engineering (Beijing, China), 2021 - ncbi.nlm.nih.gov
On 24 February 2021, a month after announcing the project, the biotechnology company
Moderna (Cambridge, MA, USA) sent samples to the US National Institutes of Health (NIH) …
Moderna (Cambridge, MA, USA) sent samples to the US National Institutes of Health (NIH) …
Coronavirus vaccines get a biotech boost
A Dance - Nature, 2020 - go.gale.com
In January, Barney Graham had a new vaccine ready for testing. Its target was the Nipah
virus, which had caused respiratory illness and brain infections in past outbreaks in …
virus, which had caused respiratory illness and brain infections in past outbreaks in …
[HTML][HTML] SARS-CoV-2 vaccine research and immunization strategies for improved control of the COVID-19 pandemic
Y Shao, Y Wu, Y Feng, W Xu, F Xiong, X Zhang - Frontiers of medicine, 2022 - Springer
The record speed at which Chinese scientists identified severe acute respiratory syndrome
Coronavirus 2 (SARS-CoV-2) and shared its genomic sequence with the world, has greatly …
Coronavirus 2 (SARS-CoV-2) and shared its genomic sequence with the world, has greatly …
From Bench Side to Bed-Travelling on a Road to Get a Safe and Effective Vaccine Against COVID-19, Day to Save the Life
SK Ray, S Mukherjee - Recent Patents on Biotechnology, 2022 - ingentaconnect.com
Coronavirus Disease 2019 (COVID-19) is caused by a new strain of coronavirus called
Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2). It is the most challenging …
Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2). It is the most challenging …
Application of traditional vaccine development strategies to SARS-CoV-2
Over the past 150 years, vaccines have revolutionized the relationship between people and
disease. During the COVID-19 pandemic, technologies such as mRNA vaccines have …
disease. During the COVID-19 pandemic, technologies such as mRNA vaccines have …